Evidence map›Paper›PMID 32514094›Full record

ArticleNature biomedical engineering2020

High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays.

Nathalie Brandenberg, Sylke Hoehnel, Fabien Kuttler, Krisztian Homicsko, Camilla Ceroni, Till Ringel, Nikolce Gjorevski, Gerald Schwank, George Coukos, Gerardo Turcatti and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 213 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
213citing papers in PubMed, 3 pooled it
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

213 citing papers in PubMed, 3 syntheses or guidelines pooled it, 375 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

153 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Nathalie Brandenberg *Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland.
Sylke Hoehnel *Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland.
Fabien Kuttler *Biomolecular Screening Facility, School of Life Sciences, EPFL, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-2575-1989
Krisztian HomicskoDepartment of Oncology, University Hospital of Lausanne, and Lausanne Branch, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
Camilla CeroniLaboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland.
Till RingelInstitute of Molecular Health Sciences, ETH Zurich, HPL, Zürich, Switzerland.
Nikolce GjorevskiLaboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland.
Gerald SchwankInstitute of Molecular Health Sciences, ETH Zurich, HPL, Zürich, Switzerland.
George CoukosDepartment of Oncology, University Hospital of Lausanne, and Lausanne Branch, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-8813-7367
Gerardo TurcattiBiomolecular Screening Facility, School of Life Sciences, EPFL, Lausanne, Switzerland.
Matthias P LutolfLaboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland. matthias.lutolf@epfl.ch.ORCID http://orcid.org/0000-0002-5898-305X
Bioscience Research · USÉcole Polytechnique Fédérale de Lausanne · CHETH Zurich · CHUniversity Hospital of Lausanne · CHRoche (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem-cell-derived epithelial organoids are routinely used for the biological and biomedical modelling of tissues. However, the complexity, lack of standardization and quality control of stem cell culture in solid extracellular matrices hampers the routine use of the organoids at the industrial scale. Here, we report the fabrication of microengineered cell culture devices and scalable and automated methods for suspension culture and real-time analysis of thousands of individual gastrointestinal organoids trapped in microcavity arrays within a polymer-hydrogel substrate. The absence of a solid matrix substantially reduces organoid heterogeneity, which we show for mouse and human gastrointestinal organoids. We use the devices to screen for anticancer drug candidates with patient-derived colorectal cancer organoids, and apply high-content image-based phenotypic analyses to reveal insights into mechanisms of drug action. The scalable organoid-culture technology should facilitate the use of organoids in drug development and diagnostics.

Indexed as

AnimalsCell AggregationCell Culture TechniquesCells, CulturedDimethylpolysiloxanesDrug Evaluation, PreclinicalHigh-Throughput Screening AssaysHumansHydrogelsIntestinesMiceOrganogenesisOrganoidsStem CellsDimethylpolysiloxanesHydrogels

Identifiers

PMID32514094
OpenAlexW3033755050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.